The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer

Abstract CULLIN3‐based E3 ubiquitin ligase substrate‐binding adaptor gene SPOP is frequently mutated in prostate cancer (PCa). PCa harboring SPOP hotspot mutants (e.g., F133V) are resistant to BET inhibitors because of aberrant elevation of BET proteins. Here, we identified a previously unrecognized...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yuqian Yan, Jian Ma, Dejie Wang, Dong Lin, Xiaodong Pang, Shangqian Wang, Yu Zhao, Lei Shi, Hui Xue, Yunqian Pan, Jun Zhang, Claes Wahlestedt, Francis J Giles, Yu Chen, Martin E Gleave, Collin C Collins, Dingwei Ye, Yuzhuo Wang, Haojie Huang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Springer Nature 2019-09-01
סדרה:	EMBO Molecular Medicine
נושאים:	BRD4 CBP/p300 NEO2734 prostate cancer SPOP
גישה מקוונת:	https://doi.org/10.15252/emmm.201910659
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!